These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 18321548
1. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):314-8. PubMed ID: 18321548 [Abstract] [Full Text] [Related]
2. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, de Carvalho E Fonseca LR, Franca Md, Lima AS. Transpl Infect Dis; 2009 Apr; 11(2):132-6. PubMed ID: 18983416 [Abstract] [Full Text] [Related]
4. Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini P. Anaesthesia; 2010 Mar; 65(3):298-301. PubMed ID: 20003112 [Abstract] [Full Text] [Related]
5. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients]. Corti M, Villafañe MF, Trione N, Risso D, Abuín JC, Palmieri O. Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146 [Abstract] [Full Text] [Related]
6. Strongyloides stercoralis hyperinfection in a patient with AIDS. Bava AJ, Troncoso AR. J Int Assoc Physicians AIDS Care (Chic); 2009 Jun; 8(4):235-8. PubMed ID: 19498213 [Abstract] [Full Text] [Related]
9. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S. Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097 [Abstract] [Full Text] [Related]
10. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Pacanowski J, Santos MD, Roux A, LE Maignan C, Guillot J, Lavarde V, Cornet M. Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846 [Abstract] [Full Text] [Related]
12. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Carvalho EM, Da Fonseca Porto A. Parasite Immunol; 2004 Aug 30; 26(11-12):487-97. PubMed ID: 15771684 [Abstract] [Full Text] [Related]
13. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Segarra-Newnham M. Ann Pharmacother; 2007 Dec 30; 41(12):1992-2001. PubMed ID: 17940124 [Abstract] [Full Text] [Related]
14. Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction. Leang B, Lynen L, Tootill R, Griffiths S, Monchy D. Lepr Rev; 2004 Dec 30; 75(4):398-403. PubMed ID: 15682976 [Abstract] [Full Text] [Related]
15. Strongyloides hyperinfection syndrome--an unappreciated opportunistic infection. Sekhar U, Madan M, Ranjitham M, Abraham G, Eapen G. J Assoc Physicians India; 2000 Oct 30; 48(10):1017-9. PubMed ID: 11200903 [Abstract] [Full Text] [Related]
16. Strongyloides stercoralis hyperinfection syndrome in patients on prolonged steroid treatment: two case reports. Koticha A, Kuyare S, Nair J, Athvale A, Mehta P. J Indian Med Assoc; 2013 Apr 30; 111(4):272-4. PubMed ID: 24475564 [Abstract] [Full Text] [Related]
19. Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible. Shield JM, Page W. P N G Med J; 2008 Apr 30; 51(3-4):105-19. PubMed ID: 21061942 [Abstract] [Full Text] [Related]
20. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection]. Richter J, Schwarz U, Duwe S, Ellerbrok H, Poggensee G, Pauli G. Dtsch Med Wochenschr; 2005 Apr 22; 130(16):1007-10. PubMed ID: 15830313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]